Julie Hambleton's most recent trade in SpringWorks Therapeutics Inc was a trade of 15,318 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| SpringWorks Therapeutics Inc | Hambleton Julie | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 15,318 | 0 | - | - | Stock Option (Right to Buy) | |
| SpringWorks Therapeutics Inc | Hambleton Julie | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 14,668 | 0 | - | - | Stock Option (Right to Buy) | |
| SpringWorks Therapeutics Inc | Julie Hambleton | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 14,155 | 0 (0%) | 0% | - | Common Stock | |
| SpringWorks Therapeutics Inc | Julie Hambleton | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 12,216 | 0 | - | - | Stock Option (Right to Buy) | |
| Erasca Inc | Julie Hambleton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2025 | 120,000 | 120,000 | - | - | Stock option (right to buy) | |
| SpringWorks Therapeutics Inc | Julie Hambleton | Director | 14 May 2025 | 10,060 | 14,155 (0%) | 0% | 0 | Common Stock | ||
| SpringWorks Therapeutics Inc | Julie Hambleton | Director | 10 Feb 2025 | 13,774 | 17,869 (0%) | 0% | 32.3 | 444,487 | Common Stock | |
| SpringWorks Therapeutics Inc | Julie Hambleton | Director | 10 Feb 2025 | 13,774 | 0 | - | - | Stock Option (Right to Buy) | ||
| SpringWorks Therapeutics Inc | Julie Hambleton | Director | 10 Feb 2025 | 13,774 | 4,095 (0%) | 0% | 53.0 | 730,207 | Common Stock | |
| IGM Biosciences Inc | Julie Hambleton | Director | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 25 Jul 2024 | 15,132 | 2,000 (0%) | 0% | 14 | 211,848 | Common Stock |
| IGM Biosciences Inc | Julie Hambleton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jul 2024 | 15,132 | 0 | - | - | Stock Option (right to buy) | |
| IGM Biosciences Inc | Julie Hambleton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share. | 25 Jul 2024 | 15,132 | 17,132 (0%) | 0% | 1.4 | 21,033 | Common Stock |
| Erasca Inc | Julie Hambleton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| SpringWorks Therapeutics Inc | Julie Hambleton | Director | 03 Jun 2024 | 2,946 | 5,797 (0%) | 0% | 39.4 | 116,111 | Common Stock | |
| SpringWorks Therapeutics Inc | Julie Hambleton | Director | 03 Jun 2024 | 931 | 4,115 (0%) | 0% | 41.5 | 38,629 | Common Stock | |
| SpringWorks Therapeutics Inc | Julie Hambleton | Director | 03 Jun 2024 | 751 | 5,046 (0%) | 0% | 40.6 | 30,465 | Common Stock | |
| SpringWorks Therapeutics Inc | Julie Hambleton | Director | 03 Jun 2024 | 20 | 4,095 (0%) | 0% | 42.1 | 842 | Common Stock | |
| SpringWorks Therapeutics Inc | Julie Hambleton | Director | 16 May 2024 | 12,216 | 12,216 | - | - | Stock Option (Right to Buy) | ||
| SpringWorks Therapeutics Inc | Julie Hambleton | Director | 16 May 2024 | 4,095 | 8,743 (0%) | 0% | 0 | Common Stock | ||
| IGM Biosciences Inc | Julie Hambleton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2024 | 29,400 | 29,400 | - | - | Stock Option (right to buy) | |
| SpringWorks Therapeutics Inc | Julie Hambleton | Director | 19 Jul 2023 | 2,418 | 4,648 (0%) | 0% | 29.3 | 70,876 | Common Stock | |
| Erasca Inc | Julie Hambleton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| SpringWorks Therapeutics Inc | Julie Hambleton | Director | 20 Jun 2023 | 2,400 | 7,066 (0%) | 0% | 26.9 | 64,603 | Common Stock | |
| SpringWorks Therapeutics Inc | Julie Hambleton | Director | 24 May 2023 | 13,774 | 13,774 | - | - | Stock Option (Right to Buy) | ||
| SpringWorks Therapeutics Inc | Julie Hambleton | Director | 24 May 2023 | 4,648 | 9,466 (0%) | 0% | 0 | Common Stock | ||
| IGM Biosciences Inc | Julie Hambleton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 15,500 | 15,500 | - | - | Stock Option (right to buy) | |
| SpringWorks Therapeutics Inc | Julie Hambleton | Director | 15 Mar 2023 | 1,106 | 4,818 (0%) | 0% | 31.5 | 34,841 | Common Stock | |
| Erasca Inc | Julie Hambleton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| SpringWorks Therapeutics Inc | Julie Hambleton | Director | 19 May 2022 | 15,318 | 15,318 | - | - | Stock Option (Right to Buy) | ||
| SpringWorks Therapeutics Inc | Julie Hambleton | Director | 19 May 2022 | 4,818 | 5,924 (0%) | 0% | 0 | Common Stock | ||
| IGM Biosciences Inc | Julie Hambleton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2022 | 29,497 | 29,497 | - | - | Stock Option (right to buy) | |
| IGM Biosciences Inc | Julie Hambleton | Director | Sale of securities on an exchange or to another person at price $ 80.00 per share. | 09 Aug 2021 | 1,000 | 2,000 (0%) | 0% | 80 | 80,000 | Common Stock |
| Erasca Inc | Julie Hambleton | Director | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 20 Jul 2021 | 6,000 | 6,000 | - | 16 | 96,000 | Common Stock |
| IGM Biosciences Inc | Julie Hambleton | Director | Sale of securities on an exchange or to another person at price $ 80.00 per share. | 01 Jun 2021 | 2,000 | 3,000 (0%) | 0% | 80 | 160,000 | Common Stock |
| SpringWorks Therapeutics Inc | Julie Hambleton | Director | 20 May 2021 | 6,998 | 6,998 | - | - | Stock Option (Right to Buy) | ||
| SpringWorks Therapeutics Inc | Julie Hambleton | Director | 20 May 2021 | 1,106 | 5,995 (0%) | 0% | 0 | Common Stock | ||
| IGM Biosciences Inc | Julie Hambleton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2021 | 6,423 | 6,423 | - | - | Stock Option (right to buy) |